Aspire Private Capital, LLC - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 62 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q1 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Aspire Private Capital, LLC ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q2 2022$0–2000.0%0.00%–
Q1 2022$0–200
+100.0%
0.00%–
Q4 2021$0
-100.0%
1000.0%0.00%–
Q3 2021$1,000
-50.0%
1000.0%0.00%
-100.0%
Q2 2021$2,000–100–0.00%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q1 2022
NameSharesValueWeighting ↓
AJ WEALTH STRATEGIES, LLC 36,001$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders